Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://bmj.com/cgi/content/full/326/7402/1286-a

BMJ Intended for Health Professionals in the US
 

Home Help Search/Archive Feedback Table of Contents

BMJ  2003;326:1286 (14 June)
 

PDF of this article
Email this article to a friend
Respond to this article
Read responses to this article
Other related articles in BMJ
PubMed citation
Related articles in PubMed
Download to Citation Manager
Alert me when:
New articles cite this article
 
Collections under which this article appears:
Regulation
Patients' views

News

Drug companies want to inform patients

Drug companies should not be excluded from giving information to patients, argued Trevor Jones, chief executive of the Association of British Pharmaceutical Industries.

"Patients want high quality information. They want independent and various sources of information so they can make informed judgments. To my mind, if you have got a condition, particularly a long term condition, you need to go in with the best information you can to get involved in a rational debate.

"Sometimes the patient is actually much more informed than the general practitioner that he is talking to. My feeling, from the pharmaceutical industry, is because we are the providers of medicines that people get from the health service, we should not be excluded from [giving information to patients], provided we do it in an objective way."

He denied suggestions that this might stoke demand for certain drugs.

"That would be true if we were to adopt the system that you see in America of direct advertising, but that is not an issue that we are addressing in the United Kingdom or Europe.

"The issue is, given that a patient is going to receive a medication of some kind, on what basis do they know what is available, and on what basis will they be able to have a rational discussion which is appropriate to them?"

They should be armed with enough information to ask why they were not getting a particular medicine or treatment, he said. (See p 1302.)


Rapid responses:

Read all Rapid responses

we all have bits of the jigsaw
susanne stevens, et al.
bmj.com, 13 Jun 2003 [Full text]
Patients as healthcare consumers
Fernando F Garcia-Abril
bmj.com, 18 Jun 2003 [Full text]

Other related articles in BMJ:

HEAD TO HEAD
Should drug companies be allowed to talk directly to patients?: YES.
Trevor Jones
BMJ 2003 326: 1302. [Full text]  

 



 

PDF of this article
Email this article to a friend
Respond to this article
Read responses to this article
Other related articles in BMJ
PubMed citation
Related articles in PubMed
Download to Citation Manager
Alert me when:
New articles cite this article
 
Collections under which this article appears:
Regulation
Patients' views


 

 


Home Help Search/Archive Feedback Table of Contents

BMJ British Journal of Opthalmology
© 2003 BMJ Publishing Group Ltd

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.